Physician profile
Jacqueline Lee Loiacono
NPI 1992401335
$2,189.73
in general payments reported to CMS, 2019-2025
15 companies · $1,017 in 2025
The $1,017 reported for 2025 was more than what 93% of Critical Care Medicine (Nurse Practitioner) providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $225 · 2024: $948 · 2025: $1,017.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,141 · Education: $48.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,140.74 |
| Education | $48.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $379.24 | 2023-2024 | Xarelto |
| Amgen INC. | $345.21 | 2023-2025 | Repatha, Repatha |
| Novo Nordisk INC | $288.85 | 2024-2025 | Ozempic, Wegovy |
| Edwards Lifesciences Corporation | $220.51 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal, Sapien 3 Ultra Resilia |
| Abiomed | $189.28 | 2024-2025 | Impella |
| Actelion Pharmaceuticals US, INC. | $180.70 | 2023-2025 | Opsumit, Uptravi |
| Novartis Pharmaceuticals Corporation | $134.68 | 2024-2025 | |
| Heartflow, INC. | $96.56 | 2024-2025 | |
| Cvrx, INC. | $71.44 | 2024-2025 | Barostim Neo System |
| Astrazeneca Pharmaceuticals Lp | $70.68 | 2024-2025 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $58.26 | 2025 | Lifevest |
| Esperion Therapeutics, INC. | $53.86 | 2025 | Nexletol |
| E.R. Squibb & Sons, L.L.C. | $51.99 | 2025 | Eliquis |
| Scpharmaceuticals INC. | $32.98 | 2025 | |
| Kestra Medical Technology Services, INC. | $15.49 | 2023 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Loiacono listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.